September 27, 2024

Real-World Data Offering from Proscia: Empowering Life Sciences to Advance Precision Medicine Pipelines

From the Proscia blog: Following a successful year-long pilot with a subset of our biopharma and biotech partners, today we announced that life sciences organizations can now leverage Proscia’s real-world data offering on the Concentriq® platform to...

recent articles

From Aiosyn via Pathology News: What is chronic kidney disease (CKD)? Chronic kidney disease (CKD) is a progressive condition where the kidneys gradually lose function [1]. It is characterized by a high morbidity and mortality rate, and it is...

Researchers from Case Western Reserve University, Cleveland Clinic and University Hospitals are using artificial intelligence to better treat rectal cancer. Doing so can help patients avoid unnecessary and invasive surgeries. It's the first...

Aim of the [Merck-Afrigen Biologics] collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Merck, a leading science and technology company, announced that its Life Science...

Published in bioRxiv, the study leverages Pangea Biomed’s ENLIGHT platform to develop a novel approach to precision cancer care that combines AI techniques and digital pathology, bypassing the need for expensive and time-consuming DNA and RNA...

Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region. New distributorship agreements have been inked with MRL Cybertec Corporation, Pathology Ware...

From the Paige blog: By now, AI’s ability to enhance diagnostic efficiency and reduce cancer detection errors is well documented, delivering benefits to pathologists and patients globally. Still, these outcomes are only the beginning of...

OR

platinum partners

gold partners

Silver Partners

Media Partners